Zacks Research Issues Positive Outlook for Itron Earnings

Itron, Inc. (NASDAQ:ITRIFree Report) – Investment analysts at Zacks Research boosted their Q4 2024 earnings estimates for shares of Itron in a report released on Tuesday, November 19th. Zacks Research analyst R. Department now expects that the scientific and technical instruments company will post earnings of $1.02 per share for the quarter, up from their previous forecast of $0.92. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q3 2025 earnings at $1.19 EPS, Q2 2026 earnings at $1.32 EPS, Q3 2026 earnings at $1.38 EPS and FY2026 earnings at $5.29 EPS.

A number of other equities analysts have also recently commented on the company. Stephens reissued an “equal weight” rating and set a $110.00 price target on shares of Itron in a report on Monday, August 5th. Robert W. Baird increased their target price on shares of Itron from $123.00 to $132.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. Oppenheimer lifted their price target on shares of Itron from $120.00 to $124.00 and gave the company an “outperform” rating in a report on Friday, November 1st. BNP Paribas began coverage on shares of Itron in a research report on Thursday, September 5th. They set an “outperform” rating and a $133.00 price objective for the company. Finally, Roth Mkm raised their target price on shares of Itron from $125.00 to $130.00 and gave the company a “buy” rating in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $123.92.

Get Our Latest Research Report on Itron

Itron Price Performance

Shares of NASDAQ:ITRI opened at $118.93 on Thursday. The firm has a 50 day moving average of $109.20 and a 200-day moving average of $104.94. Itron has a 12 month low of $65.42 and a 12 month high of $124.90. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $5.36 billion, a PE ratio of 24.09, a PEG ratio of 0.86 and a beta of 1.46.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.71. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company had revenue of $615.46 million for the quarter, compared to analysts’ expectations of $596.41 million. During the same quarter last year, the business earned $0.98 earnings per share. Itron’s revenue was up 9.8% on a year-over-year basis.

Institutional Investors Weigh In On Itron

Several institutional investors and hedge funds have recently made changes to their positions in the business. Quarry LP lifted its stake in Itron by 29.0% in the third quarter. Quarry LP now owns 454 shares of the scientific and technical instruments company’s stock valued at $48,000 after buying an additional 102 shares during the period. Continuum Advisory LLC lifted its position in shares of Itron by 42.1% during the 3rd quarter. Continuum Advisory LLC now owns 344 shares of the scientific and technical instruments company’s stock valued at $40,000 after acquiring an additional 102 shares during the period. Stifel Financial Corp boosted its stake in Itron by 2.2% during the third quarter. Stifel Financial Corp now owns 4,921 shares of the scientific and technical instruments company’s stock worth $526,000 after acquiring an additional 108 shares in the last quarter. Covestor Ltd grew its holdings in Itron by 26.1% in the third quarter. Covestor Ltd now owns 536 shares of the scientific and technical instruments company’s stock worth $57,000 after purchasing an additional 111 shares during the period. Finally, Hexagon Capital Partners LLC increased its stake in Itron by 85.6% in the second quarter. Hexagon Capital Partners LLC now owns 271 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 125 shares in the last quarter. Institutional investors own 96.19% of the company’s stock.

Insider Buying and Selling at Itron

In related news, CFO Joan S. Hooper sold 509 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $102.15, for a total value of $51,994.35. Following the transaction, the chief financial officer now owns 72,338 shares in the company, valued at $7,389,326.70. The trade was a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Thomas Deitrich sold 887 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $90,607.05. Following the sale, the chief executive officer now owns 205,276 shares of the company’s stock, valued at approximately $20,968,943.40. The trade was a 0.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,066 shares of company stock worth $4,092,737. Insiders own 1.45% of the company’s stock.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Stories

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.